[1]
M. Wieteska, M. Kurzyna, S. Szmit, and A. Torbicki, “Should a diagnosis of cancer impact the anticoagulant therapy in patients with recurrent thromboembolic disease?”, OncoReview, vol. 5, no. 2(18), pp. 62-66, May 2015.